Dr. Horiba is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
22 S Greene St
Baltimore, MD 21201Phone+1 410-328-7462Fax+1 410-328-6896
Education & Training
University of MarylandFellowship, Hematology and Medical Oncology, 2005 - 2008
Tulane UniversityResidency, Internal Medicine, 2002 - 2005- Tulane University School of MedicineClass of 2002
Certifications & Licensure
MD State Medical License 2005 - 2026
LA State Medical License 2004 - 2005
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
- Veliparib and Radiation Therapy in Treating Patients With Advanced Solid Malignancies With Peritoneal Carcinomatosis, Epithelial Ovarian, Fallopian, or Primary Peritoneal Cancer Start of enrollment: 2011 Jan 01
- Ph 3 ADI-PEG 20 Versus Placebo in Subjects With Advanced Hepatocellular Carcinoma Who Have Failed Prior Systemic Therapy Start of enrollment: 2011 Jul 01
Publications & Presentations
PubMed
- 385 citationsRandomized Phase Ib/II Study of Gemcitabine Plus Placebo or Vismodegib, a Hedgehog Pathway Inhibitor, in Patients With Metastatic Pancreatic CancerDaniel V.T. Catenacci, Melissa R. Junttila, Theodore Karrison, Nathan Bahary, M. N. Horiba
Journal of Clinical Oncology. 2015-12-20 - 46 citationsSafety, Efficacy, Pharmacokinetics, and Pharmacodynamics of the Combination of Sorafenib and TanespimycinUlka N. Vaishampayan, Angelika M. Burger, Edward A. Sausville, Lance K. Heilbrun, Jing Li
Clinical Cancer Research. 2010-07-15
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
